Key takeaways. Selling a psychiatry practice typically moves through five stages: preparation, valuation and confidential marketing, a letter of intent (LOI), due diligence, and closing. From the decision to go to market, the process commonly takes six to twelve months, though preparation can begin years earlier. Most negotiating leverage is won before marketing starts — by cleaning financials and reducing the practice’s dependence on the owner. (Illustrative — not transaction guidance.)
Question-based outline
- What’s the overall path from “thinking about it” to closing?
- Stage 1: How do I prepare a practice for sale?
- Stage 2: What happens during valuation and marketing?
- Stage 3: What is the LOI, and what should I watch for?
- Stage 4: What does due diligence involve?
- Stage 5: What happens at closing — and what comes after?
Most founder-owners sell a practice once. The process can feel opaque precisely because the people across the table — buyers and their advisors — do this constantly. The remedy is simply knowing the path. Selling a psychiatry practice generally moves through five stages, and understanding each one is how you negotiate from knowledge rather than reaction.
The shape of the process.
From the moment you decide to go to market, a sale commonly takes six to twelve months to close, depending on the complexity of diligence and whether financing is involved. (Illustrative — not transaction guidance.) The more consequential timeline, though, starts earlier: the preparation that determines your price often takes a year or more before you ever speak to a buyer.
Stage 1 — Preparation.
This is where value is made or lost. Preparation means cleaning up financials so they will survive scrutiny, separating personal expenses from the business, documenting the adjusted EBITDA a buyer will rely on, and — most importantly — reducing the degree to which the practice depends on you personally. A practice that runs without the owner in the room is worth more than one that does not. Buyers pay for earnings that continue after you leave.
Stage 2 — Valuation and confidential marketing.
With a defensible valuation in hand, the practice is taken to a curated set of qualified buyers under strict confidentiality. The word confidential is not decorative. Done well, marketing a practice never signals to staff, patients, or competitors that a sale is underway, and it surfaces multiple credible buyers rather than one — competition is what protects your terms. This stage is the strongest argument for working with an advisor who already knows which buyers are real and active.
Stage 3 — The letter of intent (LOI).
A buyer who wants to proceed submits an LOI: a mostly non-binding outline of price and key terms, usually accompanied by a request for exclusivity for a set period. The LOI is not a contract to sell, but do not treat it lightly. The structure agreed here — how much is cash at close, whether there is an earnout (a portion of the price contingent on hitting future targets), whether you are asked to roll equity into the buyer’s company — sets the frame for everything that follows. The best time to negotiate these terms is before you sign, not during diligence.
Stage 4 — Due diligence.
Once an LOI is signed, the buyer verifies everything: financials through a quality of earnings (QoE) review, payor contracts, provider agreements, compliance, and legal structure. Most deals that wobble do so here, almost always because something surfaces that preparation should have caught. A practice that was readied properly in Stage 1 moves through diligence with its price intact; one that was not often faces a renegotiation downward.
Stage 5 — Closing and beyond.
At closing, the definitive agreements are signed and funds change hands. But the deal frequently does not end there. Many psychiatry transactions include a transition period in which the selling clinician stays on, an earnout that pays out over the following years, or rollover equity that ties part of your outcome to the buyer’s future performance. Understanding these tails — before you sign — is part of understanding what you are actually agreeing to.
The single most useful thing a founder can do is start early. Knowing the stages, and preparing the practice well before going to market, is what turns a sale from something done to you into something you direct. When you want a confidential read on your own readiness and timeline, that conversation is with an advisor who works exclusively in this sector — the team at Olympic M&A.
This content is for informational purposes only and does not constitute legal, tax, accounting, or investment advice. Every transaction is unique; consult qualified advisors regarding your specific situation.
